The non-invasive treatment is shaped by 192 simultaneously focused beams of ionizing radiation that have sufficient penetration to reach even the most deeply seated tumors. The system delivers prescribed doses/shots of radiation, in compliance with a treatment plan, to the exact target site, thereby sparing surrounding tissues. Gamma Knife surgery has many advantages. The risk of complications, as compared to open surgery, is less and it is a gentler form of treatment for the patient. Gamma Knife surgery can normally be performed in a day, and convalescence is extremely short. The technique, supported by over three decades of clinical practice, is performed for over 50,000 patients each year. To date, more than 500,000 patients around the world have undergone Gamma Knife surgery.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to help in the cure of cancer patients with curable disease and to improve the quality of life of those patients with metastatic disease, making the future possible today.
Today, Elekta solutions in oncology and '/>"/>
| SOURCE Elekta, Inc. Copyright©2009 PR Newswire. All rights reserved |